Weight-related safety outcomes of lisdexamfetamine dimesylate in children and adolescents with ADHD: Post-hoc analysis from a phase 3, randomized, double-blind, multicentre, parallel-group, placebo- and active-controlled, dose-optimized study in Europe

✍ Scribed by Zuddas, A.; Coghill, D.R.; Banaschewski, T.; Soutullo, C.; Lynes, A.; Hodgkins, P.; Gasior, M.

• Book ID: 123266623
• Publisher: Elsevier Science
• Year: 2012
• Tongue: French
• Weight: 64 KB
• Volume: 60
• Category: Article
• ISSN: 0222-9617
• DOI: 10.1016/j.neurenf.2012.04.686